Update: GeoVax Prepared to Advance GOVX-B11 HIV Vaccine to Next Clinical Trial

    NEXT STORY
    Immunicum AB (publ) Presents Updated Data from Phase II MERECA Trial of Ilixadencel in Kidney Cancer at ASCO-SITC Clinical Immuno-Oncology Symposium
    PREV STORY
    Generex Provides Stock Dividend Updates and Guidance
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    SANUWAVE Health Submits de novo Petition for FDA Review and Classification of the dermaPACE System to Treat Diabetic Foot Ulcers

    ALPHARETTA, Ga., Aug. 11, 2016 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today announced ...

    author_avatar
    NASDAQ Market News

    Cytori Reports Fourth Quarter and Full Year 2017 Business and Financial Results

    SAN DIEGO, March 08, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics (NASDAQ:CYTX) (“Cytori” or the ...

    author_avatar
    NASDAQ Market News

    New XOMA Antibodies Unveiled at The Society for Immunotherapy of Cancer 31st Annual Meeting

    Preclinical Data from XOMA’s Novel Anti-IL-2 Immuno-oncology Monoclonal Antibodies Program to be Presented at ...

    author_avatar
    NASDAQ Market News